The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT
Open accessAbstract
1 Buprenorphine is a highly lipophilic derivative of oripavine. In rodent antinociceptive assays (writhing, tail pressure), buprenorphine had an action which was rapid in onset and of long duration; it was 25‐40 times more potent than morphine after parenteral injection and 7‐10 times more potent after oral administration. 2 The log dose‐response relationship for buprenorphine was curvilinear in mouse and rat tail flick tests with the antinociceptive effect decreasing at higher, non‐toxic doses. 3 Tolerance developed to the antinociceptive activity of buprenorphine in mice. 4 No signs of abstinence were observed on naloxone challenge or after abrupt withdrawal in monkeys receiving buprenorphine chronically for one month. 5 Buprenorphine antagonized the antinociceptive actions of morphine in mouse and rat tail flick tests but was an ineffective antagonist in the rat tail pressure test. 6 Buprenorphine precipitated signs of abstinence in morphine‐dependent mice and monkeys but not in morphine‐dependent rats. 7 Buprenorphine produced Straub tails in mice. This effect was not antagonized when the animals were pretreated with naloxone. However, in the rat tail pressure test high doses of diprenorphine antagonized established antinociceptive effects of buprenorphine. 8 It is concluded that buprenorphine represents a definite advance in the search for a narcotic antagonist analgesic of low physical dependence potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Bl�sig, J., Herz, A., Reinhold, K., & Zieglg�nsberger, S. (1973) · Psychopharmacologia · doi:10.1007/bf00428791 · Cited by 521
Hendershot, L. C., & Forsaith, J. (1959) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12981-9 · Cited by 343
DEWEY, W. L., HARRIS, L. S., HOWES, J. F., & NUITE, J. A. (1970) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28712-2 · Cited by 336
THE ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT
COWAN, A., DOXEY, J. C., & HARRY, E. J. R. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07533.x · Cited by 327
Self-citationEffects of short‐ and long‐term administration of pentazocine in man
Jasinski, D. R., Martin, W. R., & Hoeldtke, R. D. (1970) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1970113385 · Cited by 120
Evaluation of nalbuphine for abuse potential
Jasinski, D. R., & Mansky, P. A. (1972) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197213178 · Cited by 110
Teiger, D. G. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29935-9 · Cited by 80
Saelens, J. K., Granat, F. R., & Sawyer, W. K. (1971) · PubMed · Cited by 72
Cowan, A. (1973) · PubMed · Cited by 35
Self-citation
Cited by
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
Buprenorphine: A Review of its Pharmacological Properties and Therapeutic Efficacy
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1979) · Drugs · doi:10.2165/00003495-197917020-00001 · Cited by 398
Buprenorphine: A Unique Drug with Complex Pharmacology
Lutfy, K., & Cowan, A. (2004) · Current Neuropharmacology · doi:10.2174/1570159043359477 · Cited by 345
Self-citation
Metadata
- Authors
- COWAN, A., LEWIS, J. W., & MACFARLANE, I. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1977-08
- Volume
- 60
- Issue
- 4
- Pages
- 537-545
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2076701694
- Cited by
- 528
- References
- 13
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT. https://app.cochat.ai/papers/10.1111/j.1476-5381.1977.tb07532.x
- The paper
- COWAN, A., LEWIS, J. W., & MACFARLANE, I. R. (1977). AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1977.tb07532.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.